• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

Corresponding author: Liu Zhanli, liuzhanlihz@126.com
DOI: 10.12201/bmr.202506.00075
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: [abstract missed]

    Key words: ; ; ; 

    Submit time: 25 June 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • Fanshuochen, Tangdiwei, Liweifeng, Qinman, Liuzili. . 2025. doi: 10.12201/bmr.202507.00070

    . 2025. doi: 10.12201/bmr.202506.00084

    LIU Xinya, ZHAO Yimeng, LI YaPing. . 2025. doi: 10.12201/bmr.202503.00070

    XuHong. Advances in the treatment of osteopenia-seropathic obesity syndrome in the elderly. 2024. doi: 10.12201/bmr.202411.00064

    Zhenghaijuan, NiuXiaohan. Research Progress of CCR and metabolic syndrome and its related diseases. 2025. doi: 10.12201/bmr.202501.00048

    wangazhen, lixinag, shijingyu, yetao, wuyuanhua. Gillan - the barre syndrome complicated by myasthenia gravis in 1 case. 2024. doi: 10.12201/bmr.202408.00038

    Xie Xiangcheng. . 2024. doi: 10.12201/bmr.202412.00076

    Liu Lingyan. Ferroptosis and endoplasmic reticulum stress in polycystic ovary syndrome and related potential therapeutic targets. 2025. doi: 10.12201/bmr.202507.00042

    Zhang Han, Chu Mengyuan, Xu Kaikai, Xiang Xin, Yan Ying. Progress in Mechanism of Action of Isthmin1 Protein in Polycystic Ovary Syndrome. 2024. doi: 10.12201/bmr.202411.00004

    tanmeixiu. . 2025. doi: 10.12201/bmr.202508.00036

  • ID Submit time Number Download
    1 2025-06-15

    10.12201/bmr.202506.00075V1

    Download
  • Public  Anonymous  To author only

Get Citation

Liu Zhanli. [title missed]. 2025. biomedRxiv.202506.00075

Article Metrics

  • Read: 323
  • Download: 1
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误